Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tetsuya Urasaki
Observed names:
T. Urasaki,
TETSUYA URASAKI
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Tokyo Medical and Dental University,
Memorial Sloan Kettering Cancer Center,
University of Tokyo Hospital,
The Cancer Institute Hospital,
National Cancer Center Hospital East,
Japanese Foundation For Cancer Research,
Yaizu City Hospital
show all 7
ORCID:
0000-0002-2342-8726
Observed ORCID:
0000-0002-2342-8726
OpenAlex ID:
A5001833329
Precision medicine in breast cancer
2018
·
Yoichi Naito
, Tetsuya Urasaki
·
Chinese Clinical Oncology
·
102
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
2021
·
Akihiro Ohmoto
, Yukiko Sato
, et al.
·
Modern Pathology
·
53
PDF
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib
2020
·
NAOKI FUKUDA
, XIAOFEI WANG
, et al.
·
In Vivo
·
36
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
2020
·
NAOKI FUKUDA
, KAZUHISA TODA
, et al.
·
In Vivo
·
34
PDF
Antibodies against type II phospholipase A2 prevent renal injury due to ischemia and reperfusion in rats
1998
·
Jun Takasaki
, Yasushi Kawauchi
, et al.
·
FEBS Letters
·
33
Prognostic significance of 8 weeks’ relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients
2021
·
Naoki Fukuda
, Kazuhisa Toda
, et al.
·
Endocrine Journal
·
26
PDF
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer
2021
·
YASUYOSHI SATO
, NAOKI FUKUDA
, et al.
·
In Vivo
·
25
PDF
Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis
2020
·
Kenji Nakano
, Masatoshi Nishizawa
, et al.
·
Oxford Medical Case Reports
·
24
Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome
2021
·
Tetsuya Urasaki
, Makiko Ono
, et al.
·
Frontiers in Oncology
·
23
PDF
Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan
2021
·
Motohiro Fujiwara
, Takeshi Yuasa
, et al.
·
Cancer Reports
·
21
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial
2020
·
Yasuyoshi Sato
, Naoki Fukuda
, et al.
·
Cancer Management and Research
·
21
PDF
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma
2021
·
Yasuyoshi Sato
, Kenji Nakano
, et al.
·
Cancers
·
16
PDF
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin
2023
·
Yu Fujiwara
, Yasuyoshi Sato
, et al.
·
Journal of Geriatric Oncology
·
14
Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib
2021
·
NAOKI FUKUDA
, KAZUHISA TODA
, et al.
·
Anticancer Research
·
14
PDF
Recent Advances in Medical Therapy for Urological Cancers
2022
·
Takeshi Yuasa
, Tetsuya Urasaki
, et al.
·
Frontiers in Oncology
·
11
PDF
Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative review
2025
·
Ryosuke Oki
, Kosuke Takemura
, et al.
·
Expert Review of Anticancer Therapy
·
10
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor
2021
·
Koichi Takeda
, Kenji Nakano
, et al.
·
Rheumatology
·
10
Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma
2021
·
YASUYOSHI SATO
, KENJI NAKANO
, et al.
·
Anticancer Research
·
10
PDF
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients
2020
·
Naoki Fukuda
, Mayu Yunokawa
, et al.
·
Cancer Reports
·
10
PDF
Adult genitourinary sarcoma: The era of optional chemotherapeutic agents for soft tissue sarcoma
2020
·
Tetsuya Urasaki
, Kenji Nakano
, et al.
·
International Journal of Urology
·
10
Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma
2019
·
KUNIKI KAWAGUCHI
, KENJI NAKANO
, et al.
·
In Vivo
·
10
PDF
Prognostic Significance of Immune-related Adverse Events in Metastatic Renal Cell Carcinoma Patients Treated With Immune-checkpoint-inhibitors
2023
·
YOSUKE YASUDA
, RYO FUJIWARA
, et al.
·
Cancer Diagnosis & Prognosis
·
9
PDF
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line
2020
·
Kenji Nakano
, Keiko Hayakawa
, et al.
·
Molecular and Clinical Oncology
·
9
PDF
First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part
2023
·
Toshihiko Doi
, Nobuaki Matsubara
, et al.
·
Cancer
·
8
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients
2022
·
Naoki Fukuda
, Kazuhisa Toda
, et al.
·
Endocrine
·
8
Show more works
View as search
Works count:
67
Citation count:
636
H-index:
14
I10-index:
21
Year
Topic
Type